XML 137 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Schedule of Operations by Reportable Segment (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Segment Reporting Information [Line Items]        
Revenue $ 11,771,000 $ 4,185,000 $ 24,064,000 $ 8,653,000
Depreciation and amortization 3,158,000 817,000 6,425,000 1,335,000
Interest expense 121,000 106,000 1,499,000 126,000
Interest income 139,000 1,485,000 295,000 1,537,000
Amortized debt discount      
Stock based compensation (30,000) 4,000 (15,000)
Net income (loss) from continuing operations (5,410,000) (10,725,000) (14,361,000) (14,787,000)
Capital expenditures 269,000 7,710,000 976,000 7,828,000
Identifiable assets 282,948,000 191,161,000 282,948,000 191,161,000
Impairment of goodwill      
Income tax benefit 1,854,000 2,691,000
Operating Segments [Member] | Product Packaging [Member]        
Segment Reporting Information [Line Items]        
Revenue 3,599,000 3,376,000 7,168,000 7,237,000
Depreciation and amortization 177,000 191,000 357,000 307,000
Interest expense 34,000 19,000 58,000 39,000
Interest income 1,000      
Amortized debt discount      
Stock based compensation 1,000 1,000 1,000
Net income (loss) from continuing operations 365,000 65,000 323,000 283,000
Capital expenditures 254,000 1,202,000 943,000 1,202,000
Identifiable assets 26,688,000 29,463,000 26,688,000 29,463,000
Impairment of goodwill      
Income tax benefit    
Operating Segments [Member] | Commercial Banking [Member]        
Segment Reporting Information [Line Items]        
Revenue 831,000 960,000
Depreciation and amortization
Interest expense
Interest income      
Amortized debt discount      
Stock based compensation
Net income (loss) from continuing operations 25,000 207,000
Capital expenditures
Identifiable assets 52,416,000 52,416,000
Impairment of goodwill      
Income tax benefit    
Operating Segments [Member] | Direct Marketing Online Sales [Member]        
Segment Reporting Information [Line Items]        
Revenue 6,111,000 809,000 13,043,000 1,416,000
Depreciation and amortization 159,000 274,000 208,000 319,000
Interest expense (321,000) 2,000 2,000
Interest income 2,000      
Amortized debt discount      
Stock based compensation
Net income (loss) from continuing operations 892,000 (5,985,000) (3,472,000) (7,785,000)
Capital expenditures 12,000 14,000 6,000
Identifiable assets 52,267,000 44,772,000 52,267,000 44,772,000
Impairment of goodwill      
Income tax benefit    
Operating Segments [Member] | Biotechnology [Member]        
Segment Reporting Information [Line Items]        
Revenue 94,000 94,000
Depreciation and amortization 278,000 278,000 556,000 556,000
Interest expense 1,000 1,000
Interest income 91,000      
Amortized debt discount      
Stock based compensation
Net income (loss) from continuing operations (673,000) (610,000) (1,289,000) (1,308,000)
Capital expenditures
Identifiable assets 56,524,000 53,717,000 56,524,000 53,717,000
Income tax benefit    
Operating Segments [Member] | Securities [Member]        
Segment Reporting Information [Line Items]        
Revenue 823,000 2,497,000
Depreciation and amortization 2,530,000 5,216,000
Interest expense 408,000 67,000 1,441,000 67,000
Interest income 34,000      
Amortized debt discount      
Stock based compensation
Net income (loss) from continuing operations (3,332,000) (173,000) (5,838,000) (231,000)
Capital expenditures 2,000 6,565,000 15,000 6,565,000
Identifiable assets 85,436,000 10,939,000 85,436,000 10,939,000
Income tax benefit    
Operating Segments [Member] | Corporate Segment [Member]        
Segment Reporting Information [Line Items]        
Revenue 313,000 302,000
Depreciation and amortization 14,000 74,000 88,000 153,000
Interest expense 17,000 17,000
Interest income 11,000      
Amortized debt discount      
Stock based compensation (31,000) 3,000 (16,000)
Net income (loss) from continuing operations (2,687,000) (4,022,000) (4,292,000) (5,746,000)
Capital expenditures 1,000 (57,000) 4,000 55,000
Identifiable assets $ 9,617,000 52,270,000 9,617,000 52,270,000
Impairment of goodwill      
Income tax benefit     $ 2,691,000